Doses [qnco]
17 beta-Estradiol [horm, phsu, strd]
C-reactive protein [aapp, imft]
Interleukin-6 [aapp, imft]
Lipids [lipd]
Old [tmco]
Women [popg]
Authors [prog]
Evaluated [ftcn]
Doses [qnco]
mg day [qnco]
mg day [qnco]
mg day [qnco]
micronized estradiol [orch, phsu]
C-reactive protein [aapp, imft]
IL6 [aapp, imft]
Lipids [lipd]
Compared [acty]
placebo [topp]
Health [idcn]
Old [tmco]
Women [popg]
Participating [ftcn]
Osteoporosis [dsyn]
Study [mnob]
Methods [inpr]
randomized [resa]
Double-Blind Study [resa]
placebo-controlled [resa]
Conduct [inbe]
University [mnob, orgt]
Clinical Center [orgt]
participants [popg]
Healthy Living [idcn]
Community [geoa]
Women [popg]
Old [tmco]
Primary Outcome Measure [inpr]
Study [mnob]
bone metabolism [ortf]
Estimated [qnco]
Urine [bdsu]
Marker [clna]
Bone [bpoc]
turnover [qnco]
Authors [prog]
Measured [qlco]
Serum Markers [qlco]
C-reactive protein [aapp, imft]
IL6 [aapp, imft]
Lipids [lipd]
intracellular [celc]
Adhesion Molecule [aapp, bacs]
E-Selectin [aapp, imft, rcpt]
baseline [bodm]
weeks [tmco]
treatment [ftcn]
weeks [tmco]
treatment [ftcn]
Dose [qnco]
Response [orga]
Estrogen [horm, phsu, strd]
Occurred [acty]
C-reactive protein level [lbpr]
weeks [tmco]
treatment [ftcn]
C-reactive protein [aapp, imft]
Decreased [qnco]
mg day [qnco]
Group [idcn]
Increased [qnco]
I group [clna]
mg day [qnco]
Compared [acty]
placebo [topp]
C-reactive protein level [lbpr]
Continued [idcn]
Elevated [qlco]
Compared [acty]
placebo [topp]
weeks [tmco]
treatment [ftcn]
Discontinued [fndg]
I group [clna]
mg day [qnco]
High density lipoprotein [aapp, bacs, lipd]
Cholesterol, HDL2 [bacs, strd]
Increased [qnco]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Decreased [qnco]
weeks [tmco]
I group [clna]
mg day [qnco]
Dose [qnco]
Response [orga]
E-Selectin [aapp, imft, rcpt]
Decreased [qnco]
I group [clna]
mg day [qnco]
weeks [tmco]
Discontinuation [hlca]
treatment [ftcn]
Dose [qnco]
Response [orga]
Doses [qnco]
Affect [menp]
Parameters [fndg]
Cholesterol, HDL3 [bacs, strd]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
intracellular [celc]
Adhesion Molecule [aapp, bacs]
IL6 [aapp, imft]
Dose [qnco]
Conclusions [idcn]
C-reactive protein [aapp, imft]
Inflammation [patf]
Marker [clna]
Increased [qnco]
Cardiovascular disease [dsyn]
Decreased [qnco]
Women [popg]
Take [hlca]
Low dose [qnco]
Estrogen [horm, phsu, strd]
Increased [qnco]
Women [popg]
Assigned [ftcn]
High dose [qnco]
Estrogen [horm, phsu, strd]
Suggest [idcn]
Decreased [qnco]
Inflammation [patf]
Low dose [qnco]
3 Months [tmco]
treatment [ftcn]
Mg+2 [elii, phsu]
Same [qlco]
effects [qlco]
High density lipoprotein [aapp, bacs, lipd]
Cholesterol, LDL [bacs, strd]
i e [diap, inpr]
mg day [qnco]
Suggest [idcn]
Estradiol [horm, phsu, strd]
Doses [qnco]
Differential [qlco]
Short-term [tmco]
effects [qlco]
Marker [clna]
Cardiovascular disease [dsyn]
Low dose [qnco]
Decreased [qnco]
C-reactive protein [aapp, imft]
Marker [clna]
Inflammation [patf]
Affect [menp]
Lipid [lipd]
Parameters [fndg]
High dose [qnco]
Increased [qnco]
C-reactive protein [aapp, imft]
Lipid [lipd]
Parameters [fndg]
consequences [ftcn]
effects [qlco]
Unknown [qlco]
Estradiol [horm, phsu, strd]
Dose [qnco]
considered [idcn]
Risk Ratio [qnco]
Benefit [qnco]
Evaluated [ftcn]
Women [popg]
Estrogen Replacement Therapy [topp]
Initiate [idcn]
